Skip to main content

Table 3 Comparison between the two studied groups according to median and IQR of Fibroscan

From: Role of Fibroscan for early detection of hepatocellular carcinoma (HCC) in hepatitis C cirrhotic patients

 

Group I (n = 25)

Group II (n = 25)

T

P

Median of Fibroscan

 Min.–Max.

18.0–68.5

14.0–36.0

18.086*

< 0.003*

 Mean ± SD

42.08 ± 6.92

25.2 ± 3.0

 Median

40.0

24

IQR of Fibroscan

 Min.–Max.

4.0–16.0

1.80–11.60

16.723*

< 0.003*

 Mean ± SD

9.08 ± 0.81

5.21 ± 0.27

 Median

8.0

4.8